Related references
Note: Only part of the references are listed.Comparison of putative BH3 mimetics AT-101, HA14-1, sabutoclax and TW-37 with ABT-737 in platelets
Hao Wei et al.
PLATELETS (2021)
Cancer stem cells targets and combined therapies to prevent cancer recurrence
Pawan Kumar Raghav et al.
LIFE SCIENCES (2021)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
A novel EZH2 inhibitor induces synthetic lethality and apoptosis in PBRM1-deficient cancer cells
Kejia Huang et al.
CELL CYCLE (2020)
NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target
Alessandro Gambella et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
Raluca Ioana Teleanu et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death
I-Lun Hsin et al.
CANCERS (2020)
FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention
Antonella De Luca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Trastuzumab: More than a Guide in HER2-Positive Cancer Nanomedicine
Celia Nieto et al.
NANOMATERIALS (2020)
Novel Approaches to Target Mutant FLT3 Leukaemia
Joerg P. Mueller et al.
CANCERS (2020)
Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent
Nur Najmi Mohamad Anuar et al.
FRONTIERS IN PHARMACOLOGY (2020)
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene
Melyssa S. Roberts et al.
BREAST CANCER RESEARCH (2020)
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
Man Yee T. Keung et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
Masahiro Shibata et al.
CANCERS (2019)
The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis
Stephen P. Ducray et al.
CANCERS (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
Boron in drug design: Recent advances in the development of new therapeutic agents
Guilherme Felipe Santos Fernandes et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Smart Targeting To Improve Cancer Therapeutics
Moraima Morales-Cruz et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Targeting FLT3 mutations in AML: review of current knowledge and evidence
Naval Daver et al.
LEUKEMIA (2019)
Recent Advances and Perspectives in Cancer Drug Design
Luma G. Magalhaes et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2018)
Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer
Gregorio Peron et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
BCL-2 as therapeutic target for hematological malignancies
Guilherme Fleury Perini et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
The pathophysiology of cancer-related fatigue: current controversies
C. M. O'Higgins et al.
SUPPORTIVE CARE IN CANCER (2018)
Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance
Dilana Staudt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Stem cell factor and NSC87877 combine to enhance c-Kit mediated proliferation of human megakaryoblastic cells
Pawan Kumar Raghav et al.
PLOS ONE (2018)
The architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers
Laura C. Zanetti-Domingues et al.
NATURE COMMUNICATIONS (2018)
Biologically-based mechanistic models of radiation-related carcinogenesis applied to epidemiological data
Werner Ruehm et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2017)
Pathways and mechanisms of venetoclax resistance
Prithviraj Bose et al.
LEUKEMIA & LYMPHOMA (2017)
Anti-mitotic agents: Are they emerging molecules for cancer treatment?
Larissa Siqueira Penna et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy
Shan-Shan Qi et al.
DRUG DELIVERY (2017)
The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells
Martina Broecker-Preuss et al.
CANCER CELL INTERNATIONAL (2016)
Finally, An Apoptosis-Targeting Therapeutic for Cancer
Carlo M. Croce et al.
CANCER RESEARCH (2016)
How folate metabolism affects colorectal cancer development and treatment; a story of heterogeneity and pleiotropy
Barbara Anne Jennings et al.
CANCER LETTERS (2015)
Systematic review of pharmacologic and non-pharmacologic interventions to manage cognitive alterations after chemotherapy for breast cancer
Raymond J. Chan et al.
EUROPEAN JOURNAL OF CANCER (2015)
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Edgar Perez-Herrero et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Global cancer surgery: delivering safe, affordable, and timely cancer surgery
Richard Sullivan et al.
LANCET ONCOLOGY (2015)
Lectins with Potential for Anti-Cancer Therapy
Tammy Yau et al.
MOLECULES (2015)
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
Joel D. Leverson et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine
Sebastien Benzekry et al.
SEMINARS IN CANCER BIOLOGY (2015)
Endometrial cancer: A review and current management strategies: Part II
William M. Burke et al.
GYNECOLOGIC ONCOLOGY (2014)
Managing cancer-related fatigue in men with prostate cancer: A systematic review of non-pharmacological interventions
David Larkin et al.
INTERNATIONAL JOURNAL OF NURSING PRACTICE (2014)
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Che-Ming Jack Hu et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Protein kinase C b1 (PKCb1) inhibits the malignant phenotype of the human pancreatic tumor-derived cell line PANC1
Stefano M. Cirigliano et al.
CANCER RESEARCH (2012)
Interference Between DNA Replication and Transcription as a Cause of Genomic Instability
Yea-Lih Lin et al.
CURRENT GENOMICS (2012)
Role of Farletuzumab in Epithelial Ovarian Carcinoma
Danijela Jelovac et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Genetic Polymorphism of Estrogen Metabolizing Enzymes in Siberian Women with Breast Cancer
Ekaterina P. Khvostova et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2012)
Peptide screening to knockdown Bcl-2's anti-apoptotic activity: Implications in cancer treatment
Pawan Kumar Raghav et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2012)
Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Richard B. Womer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
An Integrated Mathematical Model of Thrombin-, Histamine-and VEGF-Mediated Signalling in Endothelial Permeability
X. N. Wei et al.
BMC SYSTEMS BIOLOGY (2011)
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
M. S. Aapro et al.
EUROPEAN JOURNAL OF CANCER (2011)
Targeted delivery of doxorubicin into cancer cells using a folic acid-dendrimer conjugate
Yin Wang et al.
POLYMER CHEMISTRY (2011)
Oxidative stress and oxidative damage in chemical carcinogenesis
James E. Klaunig et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Metastasis: cancer cell's escape from oxidative stress
Giovambattista Pani et al.
CANCER AND METASTASIS REVIEWS (2010)
Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation
M. T. Harper et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
Yanping Hu et al.
IMMUNOLOGY (2009)
ALK Gene Rearrangements A New Therapeutic Target in a Molecularly Defined Subset of Non-small Cell Lung Cancer
Benjamin Solomon et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
The BCL-2 protein family: opposing activities that mediate cell death
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Development of new cancer therapeutic agents targeting mitosis
Mark R. Miglarese et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Drug development in oncology: classical cytotoxics and molecularly targeted agents
Shivaani Kummar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
The anti-angiogenic basis of metronomic chemotherapy
RS Kerbel et al.
NATURE REVIEWS CANCER (2004)
Mitochondria: Releasing power for life and unleashing the machineries of death
DD Newmeyer et al.
CELL (2003)
Recent advances in pharmacotherapy for cancer pain management
LK Lucas et al.
CANCER PRACTICE (2002)
Share Paper
